Literature DB >> 9185701

Baldness and other correlates of sex hormones in relation to testicular cancer.

E Petridou1, K I Roukas, N Dessypris, G Aravantinos, D Bafaloukos, A Efraimidis, A Papacharalambous, D Pektasidis, G Rigatos, D Trichopoulos.   

Abstract

There is evidence that sex hormones and intrauterine factors are involved in the etiology of testicular cancer. We evaluated the importance of perinatal and adult life correlates of sex hormones as risk factors for testicular cancer in a case control study of 97 incident, histologically confirmed cases, residents of the Greater Athens area and environs, who were diagnosed in the 3 specialized cancer hospitals and the major General Hospital in Athens during the 2 year period 1993-94. Cases were age-matched to 2 healthy controls from the same study base. Both cases and controls as well as their mothers were interviewed by the same investigator and the data were analyzed through conditional logistic regression. The odds ratio for testicular cancer was elevated among persons born after a pregnancy characterized by severe nausea. Among the adult life factors, higher body mass was associated with reduced risk, as was evidence of baldness. To the extent that nausea during pregnancy reflects higher levels of pregnancy estrogens on the one hand, and baldness is linked to androgens on the other, our data suggest that estrogens in the intrauterine life and androgens at later stages may have sequential opposing effects for the development of testicular cancer.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9185701     DOI: 10.1002/(sici)1097-0215(19970611)71:6<982::aid-ijc13>3.0.co;2-8

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  21 in total

Review 1.  Clinical epidemiology of testicular germ cell tumors.

Authors:  K-P Dieckmann; U Pichlmeier
Journal:  World J Urol       Date:  2004-03-18       Impact factor: 4.226

Review 2.  A systematic review and meta-analysis of perinatal variables in relation to the risk of testicular cancer--experiences of the son.

Authors:  Michael B Cook; Olof Akre; David Forman; M Patricia Madigan; Lorenzo Richiardi; Katherine A McGlynn
Journal:  Int J Epidemiol       Date:  2010-07-26       Impact factor: 7.196

Review 3.  A systematic review and meta-analysis of perinatal variables in relation to the risk of testicular cancer--experiences of the mother.

Authors:  Michael B Cook; Olof Akre; David Forman; M Patricia Madigan; Lorenzo Richiardi; Katherine A McGlynn
Journal:  Int J Epidemiol       Date:  2009-09-23       Impact factor: 7.196

4.  Consumption of alcoholic beverages in adolescence and adulthood and risk of testicular germ cell tumor.

Authors:  Mary L Biggs; David R Doody; Britton Trabert; Jacqueline R Starr; Chu Chen; Stephen M Schwartz
Journal:  Int J Cancer       Date:  2016-08-16       Impact factor: 7.396

5.  Baldness, acne and testicular germ cell tumours.

Authors:  B Trabert; A J Sigurdson; A M Sweeney; R J Amato; S S Strom; K A McGlynn
Journal:  Int J Androl       Date:  2010-12-03

Review 6.  Etiologic factors in testicular germ-cell tumors.

Authors:  Katherine A McGlynn; Michael B Cook
Journal:  Future Oncol       Date:  2009-11       Impact factor: 3.404

Review 7.  A systematic review and meta-analysis of the relationship between body size and testicular cancer.

Authors:  C C Lerro; K A McGlynn; M B Cook
Journal:  Br J Cancer       Date:  2010-10-26       Impact factor: 7.640

Review 8.  Will Testicular Germ Cell Tumors Remain Untargetable?

Authors:  Fouad Aoun; Hampig Raphael Kourie; Simone Albisinni; Thierry Roumeguère
Journal:  Target Oncol       Date:  2016-12       Impact factor: 4.493

9.  Testicular cancer incidence trends in the USA (1975-2004): plateau or shifting racial paradigm?

Authors:  L Holmes; C Escalante; O Garrison; B X Foldi; G O Ogungbade; E J Essien; D Ward
Journal:  Public Health       Date:  2008-06-13       Impact factor: 2.427

10.  Is increased body mass index associated with the incidence of testicular germ cell cancer?

Authors:  Klaus-Peter Dieckmann; Jörg Thomas Hartmann; Johannes Classen; Malte Diederichs; Uwe Pichlmeier
Journal:  J Cancer Res Clin Oncol       Date:  2008-11-11       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.